SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-014343
Filing Date
2017-08-10
Accepted
2017-08-10 08:03:28
Documents
56
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20170630_10q.htm 10-Q 733997
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15456
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 15467
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5695
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5990
  Complete submission text file 0001437749-17-014343.txt   3949490

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS snbp-20170630.xml EX-101.INS 766421
7 EXHIBIT 101.SCH snbp-20170630.xsd EX-101.SCH 45080
8 EXHIBIT 101.CAL snbp-20170630_cal.xml EX-101.CAL 27926
9 EXHIBIT 101.DEF snbp-20170630_def.xml EX-101.DEF 291340
10 EXHIBIT 101.LAB snbp-20170630_lab.xml EX-101.LAB 246570
11 EXHIBIT 101.PRE snbp-20170630_pre.xml EX-101.PRE 310740
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 171019764
SIC: 2834 Pharmaceutical Preparations